Research programme: neuroprotectants - Bionure
Alternative Names: BN-119Latest Information Update: 06 Jun 2018
At a glance
- Originator Bionure
- Class Peptoids; Small molecules
- Mechanism of Action TrkA receptor agonists; TrkB receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Amyotrophic lateral sclerosis; Glaucoma; Multiple sclerosis; Parkinson's disease
Most Recent Events
- 29 May 2018 Discontinued - Preclinical for Glaucoma in Spain (Ophthalmic)
- 29 May 2018 Discontinued - Preclinical for Multiple sclerosis in Spain (IV)
- 29 May 2018 Discontinued - Preclinical for Multiple sclerosis in Spain (PO)